Hamper M et al., 2021-10-08: Single case report of a patient with Kleine-Levin syndrome treated with intranasal red-light photobiomodulation together with methylene blue, after which the episode remitted. It is patient-level experience, not a controlled test of the combination.
The parents of the patient agreed to attempt a trial of intranasal photobiomodulation (i-PBM) with red light, in combination with methylene blue (MB).
Hamper M et al., 2021-10-08: Single case report of a patient with Kleine-Levin syndrome treated with intranasal red-light photobiomodulation together with methylene blue, after which the episode remitted. It is patient-level experience, not a controlled test of the combination. Study type: case report. N=1 (adolescent). Country: United States (Massachusetts General Hospital authors). Dose/route: intranasal photobiomodulation with red light plus methylene blue; exact dose, wavelength and fluence not stated in the abstract (see paper). Comparator: none; prior treatments had failed. Result: remission of the KLS episode, no further episodes reported. COI: 'The authors have declared financial relationships, which are detailed in the next section.' Note: a single case cannot separate the effect of light, methylene blue, or natural remission. Study type: case report.
